Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oriol Gasch

Showing results (31-40 of 55) with videos related to

Pageof 6
Sort By:
The Journal of Antimicrobial Chemotherapy|August 28, 2020
Cloxacillin or fosfomycin plus daptomycin combinations are more active than cloxacillin monotherapy or combined with gentamicin against MSSA in a rabbit model of experimental endocarditisCristina García-de-la-Mària, Oriol Gasch, Ximena Castañeda, et al.
The Journal of Infection|January 3, 2016
Clinical characteristics, treatment and outcomes of MRSA bacteraemia in the elderlyGuillermo Cuervo, Oriol Gasch, Evelyn Shaw, et al.
The Lancet Regional Health. Europe|March 6, 2026
Subphenotype- and complication-guided adjunctive fosfomycin versus standard monotherapy in <i>Staphylococcus aureus</i> bacteraemia: pooled analysis of two randomised trialsFrancesc Escrihuela-Vidal, Julia García Larrauri, Joaquín López-Contreras, et al.
Journal of Global Antimicrobial Resistance|May 8, 2021
Clinical characteristics and outcome of bacteraemia caused by Enterobacter cloacae and Klebsiella aerogenes: more similarities than differencesRocío Álvarez-Marín, José Antonio Lepe, Oriol Gasch-Blasi, et al.
The Journal of Infection|October 5, 2019
A prospective, multicenter case control study of risk factors for acquisition and mortality in Enterobacter species bacteremiaRocío Álvarez-Marín, Dolores Navarro-Amuedo, Oriol Gasch-Blasi, et al.
Surgery|June 15, 2023
The hidden side of infective endocarditis: Diagnostic and management of 500 consecutive cases in noncardiac surgery centers (2009-2018)Sonia Calzado, Marta Hernández-Meneses, Jaume Llopis, et al.
The Journal of Antimicrobial Chemotherapy|April 11, 2025
Ceftazidime/avibactam for the treatment of bloodstream infection due to carbapenemase-producing Enterobacterales in onco-haematologic neutropenic patients (the TARZAN study)Enric Sastre-Escolà, Fotinie Ntziora, Matteo Chiurlo, et al.
Open Forum Infectious Diseases|October 30, 2019
Higher MICs (>2 mg/L) Predict 30-Day Mortality in Patients With Lower Respiratory Tract Infections Caused by Multidrug- and Extensively Drug-Resistant <i>Pseudomonas aeruginosa</i> Treated With Ceftolozane/TazobactamOlga Rodríguez-Núñez, Leonor Periañez-Parraga, Antonio Oliver, et al.
Microorganisms|January 8, 2025
In Vitro Activity of Ampicillin Plus Ceftriaxone Against Non-<i>faecalis</i> and Non-<i>faecium</i> Enterococcal Isolates With/Without VanC Phenotype: Clinical Implications for Infective EndocarditisJavier García-González, María A Cañas, Guillermo Cuervo, et al.
Antibiotics (Basel, Switzerland)|March 29, 2023
<i>Cutibacterium</i> spp. Infections after Instrumented Spine Surgery Have a Good Prognosis Regardless of Rifampin Use: A Cross-Sectional StudySusana Núñez-Pereira, Eva Benavent, Marta Ulldemolins, et al.
Pageof 6

Showing results (31-40 of 55) with videos related to

Sort By:
Pageof 6
The Journal of Antimicrobial Chemotherapy|August 28, 2020
Cloxacillin or fosfomycin plus daptomycin combinations are more active than cloxacillin monotherapy or combined with gentamicin against MSSA in a rabbit model of experimental endocarditisCristina García-de-la-Mària, Oriol Gasch, Ximena Castañeda, et al.
The Journal of Infection|January 3, 2016
Clinical characteristics, treatment and outcomes of MRSA bacteraemia in the elderlyGuillermo Cuervo, Oriol Gasch, Evelyn Shaw, et al.
The Lancet Regional Health. Europe|March 6, 2026
Subphenotype- and complication-guided adjunctive fosfomycin versus standard monotherapy in <i>Staphylococcus aureus</i> bacteraemia: pooled analysis of two randomised trialsFrancesc Escrihuela-Vidal, Julia García Larrauri, Joaquín López-Contreras, et al.
Journal of Global Antimicrobial Resistance|May 8, 2021
Clinical characteristics and outcome of bacteraemia caused by Enterobacter cloacae and Klebsiella aerogenes: more similarities than differencesRocío Álvarez-Marín, José Antonio Lepe, Oriol Gasch-Blasi, et al.
The Journal of Infection|October 5, 2019
A prospective, multicenter case control study of risk factors for acquisition and mortality in Enterobacter species bacteremiaRocío Álvarez-Marín, Dolores Navarro-Amuedo, Oriol Gasch-Blasi, et al.
Surgery|June 15, 2023
The hidden side of infective endocarditis: Diagnostic and management of 500 consecutive cases in noncardiac surgery centers (2009-2018)Sonia Calzado, Marta Hernández-Meneses, Jaume Llopis, et al.
The Journal of Antimicrobial Chemotherapy|April 11, 2025
Ceftazidime/avibactam for the treatment of bloodstream infection due to carbapenemase-producing Enterobacterales in onco-haematologic neutropenic patients (the TARZAN study)Enric Sastre-Escolà, Fotinie Ntziora, Matteo Chiurlo, et al.
Open Forum Infectious Diseases|October 30, 2019
Higher MICs (>2 mg/L) Predict 30-Day Mortality in Patients With Lower Respiratory Tract Infections Caused by Multidrug- and Extensively Drug-Resistant <i>Pseudomonas aeruginosa</i> Treated With Ceftolozane/TazobactamOlga Rodríguez-Núñez, Leonor Periañez-Parraga, Antonio Oliver, et al.
Microorganisms|January 8, 2025
In Vitro Activity of Ampicillin Plus Ceftriaxone Against Non-<i>faecalis</i> and Non-<i>faecium</i> Enterococcal Isolates With/Without VanC Phenotype: Clinical Implications for Infective EndocarditisJavier García-González, María A Cañas, Guillermo Cuervo, et al.
Antibiotics (Basel, Switzerland)|March 29, 2023
<i>Cutibacterium</i> spp. Infections after Instrumented Spine Surgery Have a Good Prognosis Regardless of Rifampin Use: A Cross-Sectional StudySusana Núñez-Pereira, Eva Benavent, Marta Ulldemolins, et al.
Pageof 6